Treating Long-Haul Syndrome

“Treating Long-Haul Syndrome” – Analysis by Dr. Joseph Mercola & Video with Dr. Mc Cullough

https://articles.mercola.com/sites/articles/archive/2021/11/20/treating-long-haul-syndrome.aspx?ui=e483286c776669007570d45ab6b6381c7f58510d2a027b1e0ca898d53746ff19&sd=20120217&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20211120&mid=DM1047279&rid=1327680903

PDF: https://media.mercola.com/ImageServer/Public/2021/November/PDF/treating-long-haul-syndrome-pdf.pdf

STORY AT-A-GLANCE

· Long-haul syndrome refers to symptoms that persist for four or more weeks after an initial COVID-19 infection

· Board-certified internist and cardiologist and editor of two medical journals Dr. Peter McCullough discusses potential treatments for long-haul syndrome

· McCullough uses full-dose aspirin — 325 milligrams a day — in almost everyone with long COVID syndrome who doesn’t have a major blood clot, in addition to other medications

· A better alternative to aspirin is digestive fibrinolytic enzymes like lumbrokinase and serrapeptase; anyone who had COVID-19, especially with significant symptoms, should consider taking digestive fibrinolytic enzymes to be sure you don’t have any clotting

· An alternative to determine if clotting is occurring is a test called D-dimer, although it can be pricey

· FLCCC’s I-RECOVER protocol can be downloaded in full, giving you step-by-step instructions on how to treat long-haul COVID syndrome and/or reactions from COVID-19 injections